FI (list display)

  • A61L31/00
  • Materials for other surgical articles [4] HB CC 4C081
  • A61L31/02
  • .Inorganic materials [7] HB CC 4C081
  • A61L31/04
  • .Macromolecular materials [7] HB CC 4C081
  • A61L31/04,100
  • ..Mixtures of macromolecular compounds HB CC 4C081
  • A61L31/04,110
  • ..obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds HB CC 4C081
  • A61L31/04,120
  • ..Natural macromolecular materials HB CC 4C081
  • A61L31/06
  • ..obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] HB CC 4C081
  • A61L31/08
  • .Materials for coatings [7] HB CC 4C081
  • A61L31/10
  • ..Macromolecular materials [7] HB CC 4C081
  • A61L31/12
  • .Composite materials, e.g. layered or containing one material dispersed in a matrix of the same or different material [7] HB CC 4C081
  • A61L31/12,100
  • ..having a macromolecular matrix HB CC 4C081
  • A61L31/12,110
  • ...containing macromolecular fillers HB CC 4C081
  • A61L31/14
  • .Materials characterised by their function or physical properties [7] HB CC 4C081
  • A61L31/14,100
  • ..Plasticizers HB CC 4C081
  • A61L31/14,200
  • ..Stabilizers HB CC 4C081
  • A61L31/14,300
  • ..Hydrogels or hydrogelcolloids HB CC 4C081
  • A61L31/14,400
  • ..Porous materials, e.g. foams or sponges HB CC 4C081
  • A61L31/14,500
  • ..Materials at least partially resorbable by the body HB CC 4C081
  • A61L31/16
  • ..Biologically active materials, e.g. therapeutic substances [7] HB CC 4C081
  • A61L31/18
  • ..Materials at least partially X-ray or laser opaque [7] HB CC 4C081
    TOP